Gardner Lewis Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.85M Sell
4,878
-270
-5% -$276K 1.3% 24
2026
Q1
$4.73M Sell
5,148
-81
-2% -$82.1K 1.03% 34
2025
Q4
$5.62M Buy
5,229
+292
+6% +$279K 1.42% 23
2025
Q3
$3.77M Sell
4,937
-54
-1% -$40.2K 0.89% 31
2025
Q2
$3.89M Buy
4,991
+145
+3% +$113K 0.97% 37
2025
Q1
$4M Buy
4,846
+2,398
+98% +$2M 0.96% 41
2024
Q4
$1.89M Sell
2,448
-2
-0.1% -$1.66K 0.46% 47
2024
Q3
$2.17M Hold
2,450
0.61% 44
2024
Q2
$2.22M Hold
2,450
0.61% 45
2024
Q1
$1.91M Buy
+2,450
New +$1.74M 0.52% 46
2022
Q1
Sell
-5,966
Closed -$1.65M 80
2021
Q4
$1.65M Buy
+5,966
New +$1.51M 0.31% 60

Other funds holding LLY

Gardner Lewis Asset Management's LLY Position: Q2 2026 in Review

Gardner Lewis Asset Management reduced its Eli Lilly (LLY) stake by 5.2% in Q2 2026, selling an estimated $276K and leaving 4,878 shares worth $5.85M. The position accounts for 1.3% of the portfolio, ranked #24.

Gardner Lewis Asset Management first reported a position in LLY in Q4 2021 and has held it in 11 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gardner Lewis Asset Management held 4,878 shares of Eli Lilly worth $5.85M as of Q2 2026.
  • Gardner Lewis Asset Management sold 270 Eli Lilly shares in Q2 2026, an estimated $276K.
  • Eli Lilly made up 1.3% of Gardner Lewis Asset Management's portfolio in Q2 2026, its #24 holding.
  • Gardner Lewis Asset Management first reported a position in Eli Lilly in Q4 2021 and has held it in 11 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.